BR9911984A - Composição contento trinitrato de gricerol, processos para sua preparação e sua aplicação - Google Patents

Composição contento trinitrato de gricerol, processos para sua preparação e sua aplicação

Info

Publication number
BR9911984A
BR9911984A BR9911984-6A BR9911984A BR9911984A BR 9911984 A BR9911984 A BR 9911984A BR 9911984 A BR9911984 A BR 9911984A BR 9911984 A BR9911984 A BR 9911984A
Authority
BR
Brazil
Prior art keywords
preparation
active substance
application
processes
trinitrate
Prior art date
Application number
BR9911984-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Achim Berthold
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of BR9911984A publication Critical patent/BR9911984A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9911984-6A 1998-07-09 1999-07-02 Composição contento trinitrato de gricerol, processos para sua preparação e sua aplicação BR9911984A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830648A DE19830648A1 (de) 1998-07-09 1998-07-09 Glyceroltrinitrathaltige Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung
PCT/EP1999/004610 WO2000002537A1 (de) 1998-07-09 1999-07-02 Glyceroltrinitrathaltige zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
BR9911984A true BR9911984A (pt) 2001-03-27

Family

ID=7873427

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911984-6A BR9911984A (pt) 1998-07-09 1999-07-02 Composição contento trinitrato de gricerol, processos para sua preparação e sua aplicação

Country Status (15)

Country Link
EP (1) EP1094793A1 (de)
JP (1) JP2002520268A (de)
KR (1) KR20010074687A (de)
CN (1) CN1308526A (de)
AU (1) AU4781499A (de)
BR (1) BR9911984A (de)
CA (1) CA2336704A1 (de)
DE (1) DE19830648A1 (de)
HU (1) HUP0104950A3 (de)
IL (1) IL140739A0 (de)
MX (1) MXPA01000127A (de)
PL (1) PL345545A1 (de)
TR (1) TR200100020T2 (de)
WO (1) WO2000002537A1 (de)
ZA (1) ZA200100173B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI287455B (en) * 2000-12-05 2007-10-01 Noven Pharma Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use
JP5681883B2 (ja) * 2009-03-27 2015-03-11 株式会社 メドレックス 核酸を有効成分とする外用剤組成物
JP5816881B2 (ja) * 2014-05-21 2015-11-18 株式会社 メドレックス 核酸を有効成分とする外用剤組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5777617A (en) * 1980-10-20 1982-05-15 Nichiban Co Ltd Plaster for cardiac disease
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JPH07116032B2 (ja) * 1990-04-06 1995-12-13 積水化学工業株式会社 ニトログリセリン貼付剤
ATE126434T1 (de) * 1991-06-10 1995-09-15 Sanol Arznei Schwarz Gmbh Nitroglycerin-pflaster und verfahren zu seiner herstellung.
DE856311T1 (de) * 1996-12-10 1999-02-25 Rotta Research B.V., Amsterdam Transdermales Arzneistoff-Verabreichungssystem zur Behandlung von Herzerkrankungen

Also Published As

Publication number Publication date
HUP0104950A2 (en) 2002-06-29
TR200100020T2 (tr) 2001-07-23
JP2002520268A (ja) 2002-07-09
ZA200100173B (en) 2001-08-10
IL140739A0 (en) 2002-02-10
MXPA01000127A (es) 2002-06-04
KR20010074687A (ko) 2001-08-09
WO2000002537A1 (de) 2000-01-20
HUP0104950A3 (en) 2002-07-29
DE19830648A1 (de) 2000-01-13
AU4781499A (en) 2000-02-01
EP1094793A1 (de) 2001-05-02
CA2336704A1 (en) 2000-01-20
CN1308526A (zh) 2001-08-15
PL345545A1 (en) 2001-12-17

Similar Documents

Publication Publication Date Title
WO2003034803A8 (en) Methods for determining toxicity reversing agents
ATE543491T1 (de) Kombinationspräparat enthaltend ibuprofen und paracetamol
SE9702457D0 (sv) Screening
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
ES8200558A1 (es) Procedimiento para producir un preparado farmaceutico en forma de una pelicula de poliacrilato, adecuado para aplicacionpor via transdermal.
EA200601253A1 (ru) Преимущественно линейная шипучая лекарственная форма фентанила для перорального применения и способы введения
BR9815439A (pt) Analgesia contìnua obtida com buprenorphine
DE69505041D1 (de) Buprenorphine enthaltendes Präparat für perkutäne Absorption
ATE305775T1 (de) Tulobuterol enthaltendes präparat für perkutane absorption
ES2074698T3 (es) Composicion oral para el tratamiento de enfermedades intestinales inflamatorias.
DK0488137T3 (da) Præparat til transdermal medikamentadministrering
BR0306306A (pt) Composição contendo extrato de matricária e uso desta
ATE183192T1 (de) Neue colon-oder ilean-spezifische steroid derivate
DK0951553T3 (da) Adenovirus-E4-proteiner til induktion af celledød
ATE220912T1 (de) Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung
BR9911984A (pt) Composição contento trinitrato de gricerol, processos para sua preparação e sua aplicação
UA35623C2 (uk) Похідні аміду фенілциклогексилкарбонової кислоти, суміш їх ізомерів чи окремі ізомери і їх солі, фармацевтична композиція з антиартеріосклеротичною і антирестенозною активністю
BRPI0412224A (pt) uso de cloreto do sódio, cloreto de sódio, emplastro, dispositivo, preparado e método de manufatura de um medicamento
ATE270551T1 (de) Kombinationspräparat aus 2-methylthiazolidin-2,4- dicarbonsäure und paracetamol
ATE89163T1 (de) Topisch anzuwendende diclofenac enthaltende arzneizubereitungen.
DK0880366T3 (da) Farmaceutisk præparat med adhæsion til huden, især et transdermalt terapeutisk system til afgivelse af 17-beta-estradiol til den menneskelige organisme
BR0312333A (pt) Terapia de combinação e agente para sua execução
ITMI20041871A1 (it) Uso di santoreggia satureja montana o dei suoi estratti per la preparazione di medicamenti per il trattamento dell'eiaculazione precoce
MD940244A (ro) Derivaţi noi ai tetrazolului, procedeu de obţinere a lor şi compoziţie farmaceutică pe baza lor
TH25313A (th) องค์ประกอบทางเภสัชที่ออกฤทธิ์ผ่านทางผิวหนังที่มีกรด 5-แอมิโนเลฟวูลินิกประกอบอยู่

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]